215 related articles for article (PubMed ID: 35064701)
1. Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis.
He K; He S; Su M
J Clin Lab Anal; 2022 Mar; 36(3):e24231. PubMed ID: 35064701
[TBL] [Abstract][Full Text] [Related]
2. Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment.
Wen N; Zhao N; Xu H; Zhao Y; Ma J
Ir J Med Sci; 2022 Oct; 191(5):2105-2111. PubMed ID: 34843071
[TBL] [Abstract][Full Text] [Related]
3. Serum interα-trypsin inhibitor heavy chain H4 may be an anti-inflammatory marker reflecting disease risk, activity and treatment outcome of ankylosing spondylitis.
Sun Z; Zhang Y; Zhou H; Li J; Zhou Y; Wang L
Scand J Clin Lab Invest; 2023 Dec; 83(8):540-547. PubMed ID: 38156824
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal change of serum inter-alpha-trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis.
Zhao X; Guo Y; Li L; Li Y
J Clin Lab Anal; 2023 Feb; 37(3):e24834. PubMed ID: 36725250
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Change of Serum Inter-α-Trypsin Inhibitor Heavy Chain H4 and its Relation with Inflammation, Disease Recurrence, and Mortality in Acute Ischemic Stroke Patients.
Zhang J; Hu J; Zhao W
Tohoku J Exp Med; 2023 Feb; 259(3):221-227. PubMed ID: 36596502
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Shinkai Y; Kumagai Y; Ishigami A; Sumida T
Arthritis Res Ther; 2018 Apr; 20(1):66. PubMed ID: 29636082
[TBL] [Abstract][Full Text] [Related]
7. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
Jin YJ; Sun L; Yang L; Xing R; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495
[TBL] [Abstract][Full Text] [Related]
8. Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Osada A; Matsumoto I; Mikami N; Ohyama A; Kurata I; Kondo Y; Tsuboi H; Ishigami A; Sano Y; Arai T; Ise N; Sumida T
Clin Exp Immunol; 2021 Mar; 203(3):385-399. PubMed ID: 33238047
[TBL] [Abstract][Full Text] [Related]
9. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
[TBL] [Abstract][Full Text] [Related]
10. Can Cytokines be used as an Activation Marker in Rheumatoid Arthritis?
Kaya FÖ; Ceylan Y; İpek BÖ; Özünal ZG; Sezgin G; Nalbant S
Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1459-1465. PubMed ID: 33076814
[TBL] [Abstract][Full Text] [Related]
11. Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in experimental arthritis murine models.
Iwai T; Ohyama A; Osada A; Nishiyama T; Shimizu M; Miki H; Asashima H; Kondo Y; Tsuboi H; Mizuno S; Takahashi S; Ishigami A; Matsumoto I
Clin Exp Immunol; 2024 Feb; 215(3):302-312. PubMed ID: 38190323
[TBL] [Abstract][Full Text] [Related]
12. The relationship of blood CDC42 level with Th1 cells, Th17 cells, inflammation markers, disease risk/activity, and treatment efficacy of rheumatoid arthritis.
Li Y; Yang W; Wang F
Ir J Med Sci; 2022 Oct; 191(5):2155-2161. PubMed ID: 34859333
[TBL] [Abstract][Full Text] [Related]
13. Potential significance of changes in serum levels of IL-17, TNF-α and DKK-1 in the progression of the rheumatoid arthritis.
Wang Q; Liu Y; Wu J; Chen S; Hu T; Liu Y; Li X; Li X; Wu Y; Yu J; Zeng T; Luo Y; Hu X; Tan LM
Autoimmunity; 2023 Dec; 56(1):2276068. PubMed ID: 37909152
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
15. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
16. Serum HDAC4 level in rheumatoid arthritis: Longitudinal change during treatment and correlation with clinical outcomes.
Mou X; Jin Y; Jin D; Guan J; Zhang Q
J Clin Lab Anal; 2022 Aug; 36(8):e24594. PubMed ID: 35792020
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NEAT1 and its targets (microRNA-21 and microRNA-125a) in rheumatoid arthritis: Altered expression and potential to monitor disease activity and treatment outcome.
Yang J; Wang S; Liu L; Wang J; Shao Y
J Clin Lab Anal; 2021 Dec; 35(12):e24076. PubMed ID: 34708894
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of detection of soluble interleukin 2 receptor alpha chain in the assessment of rheumatoid arthritis disease activity].
Xu JJ; Wang Y; Sun H; Jia RL; Zhang XW; Meng Y; Ren LL; Sun XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):975-980. PubMed ID: 30562767
[TBL] [Abstract][Full Text] [Related]
19. Assessment of IL-1β, IL-6, TNF-α, IL-8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis.
Alturaiki W; Alhamad A; Alturaiqy M; Mir SA; Iqbal D; Bin Dukhyil AA; Alaidarous M; Alshehri B; Alsagaby SA; Almalki SG; Alghofaili F; Choudhary RK; Almutairi S; Banawas S; Alosaimi B; Mubarak A
Int J Rheum Dis; 2022 Sep; 25(9):1013-1019. PubMed ID: 35748059
[TBL] [Abstract][Full Text] [Related]
20. Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis.
Boss B; Neeck G
Z Rheumatol; 2000; 59 Suppl 2():II/62-4. PubMed ID: 11155806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
